Training activity information
Details
Participate in service delivery for the somatic cancer service
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Service delivery pathways
 - Best practice guidance
 - Local and national guidance
 - Test directory
 - Service management
 - Duty scientist role
 - Service costing
 - Trouble shooting
 - Communication with other healthcare professionals
 - Quality management
 
Relevant learning outcomes
| # | Outcome | 
|---|---|
| # 1 | 
                                                Outcome 
                                                 Apply appropriate sample selection criteria for the commonly referred cancer samples, taking into account the implications of the referral with respect to sample type, sampling mixed cell populations, limits of detection, sensitivity of assay and patient management.  | 
                                        
| # 2 | 
                                                Outcome 
                                                 Select the laboratory testing strategy for the commonly referred cancer samples at all stages of the patient pathway.  | 
                                        
| # 3 | 
                                                Outcome 
                                                 Analyse, interpret and report tests for patients referred with sporadic cancer.  | 
                                        
| # 4 | 
                                                Outcome 
                                                 Analyse, interpret and report on genetic testing for circulating tumour referrals.  | 
                                        
| # 7 | 
                                                Outcome 
                                                 Analyse, interpret and report gene fusion testing in cancer referrals.  |